Muscle activation in people suffering from hip osteoarthritis might be a case of 'mind over matter', new research has shown. A recent study investigated muscle function in people with hip ...

Platelet-rich plasma (PRP) treatment involves taking blood from a patient and harvesting certain components of that blood — ...

An estimated 46 percent of American adults will develop osteoarthritis of the knee at some point. It is, by far, the most ...

Here’s our process. When you have osteoarthritis in your knees, even daily activities like walking can cause pain. Research shows a knee brace may help. We rounded up some options that can help ...

Introduction: This study examined the efficacy of a therapy based on a combination of Platelet Rich Plasma and hydroxyapatite nanoparticles in a severe clinical case involving a young Rottweiler with ...

This prospective study evaluated 22 patients who were treated with platelet-rich plasma for ... compartments of the knee. Inclusion criteria were Kellgren grade 0–II, osteoarthritis confirmed ...

But Arthrosamid® offers patients a new pathway. Unlike traditional treatments, it's proven to offer respite from knee osteoarthritis with a single treatment, and without the need for surgery.( ...

Abby Reinhard is a writer, editor, and native Jersey Girl. Before Best Life, she was working in medical writing, ... We offer the most up-to-date information from top experts, new research, and health ...

Fortunately, we now have a better understanding of the condition – and how to identify those who have it OCD is complex and commonly misunderstood, with a limited number of treatment options.

Referred to medically as osteophytes, bone spurs can develop as a result of aging, joint degeneration, mechanical instability, and chronic diseases like osteoarthritis. Bone spurs in the knee can be ...

Hyaluronic acid injections have been FDA approved for many years as a treatment for knee osteoarthritis. But the American College of Rheumatology recommends against the use of hyaluronic acid in ...

Compared with placebo, patients who received MM-II had clinically meaningful and sustained pain relief for up to 26 weeks. The Food and Drug Administration (FDA) has granted Fast Track designation ...